Literature DB >> 17309546

Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice.

B Weisz1, P Pandya, L Chitty, P Jones, W Huttly, C Rodeck.   

Abstract

We have evaluated a cohort of women booked for antenatal care at University College London Hospitals. The uptake of screening was 64.4% and was significantly higher (73 versus 46%) in women who booked before 14 weeks. Of the women who booked before 14 weeks, 96.8% opted for the integrated test (IT). Overall, 5.3% failed to attend for the second blood test. The false-positive rate in the women who had the IT was 2.9%. All 11 cases of Down syndrome were detected prenatally. Our study is the first to evaluate implementation of the IT into routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309546     DOI: 10.1111/j.1471-0528.2007.01238.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

3.  Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus.

Authors:  Wei-Lin Ke; Wei-Hua Zhao; Xin-Yu Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.

Authors:  Bin Yu; Bin Zhang; Ye Shi; Shi-He Shao; Qiu-Wei Wang; Rui-Ping Huang; Yu-Qi Yang
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

Review 5.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

6.  Screening for fetal aneuploidy and neural tube defects.

Authors:  Deborah A Driscoll; Susan J Gross
Journal:  Genet Med       Date:  2009-11       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.